Today: 19 June 2026
Browse Category

Earnings Reports 14 January 2026 - 15 January 2026

Kroger maintained its 2026 outlook after first-quarter sales exceeded forecasts, but adjusted earnings missed estimates by a cent. Shares fell in premarket trading due to margin pressure from price investments, higher transport costs, and changes in fuel mix. CarMax reported fiscal Q1 revenue of $8.01 billion, beating forecasts, driven by higher used-car prices and strong wholesale demand, though retail used-vehicle gross profit per unit declined and the company continued price cuts to boost sales. La-Z-Boy shares rebounded nearly 17% in after-hours trading after adjusted earnings beat expectations, with revenue flat year-over-year; retail expansion supported results, but same-store orders and Joybird sales remained weak. Micron Technology shares dropped 3.6% after a record close as semiconductor stocks slipped, with investors locking in profits rather than reacting to specific company news. Netflix shares declined amid deal speculation involving Roku and Lionsgate, with the next earnings date set for July 16; the stock’s outlook depends on ads, pricing, and engagement. AT&T shares dipped 1.23% before a slight premarket uptick, underperforming the broader market as telecom stocks were influenced more by rate changes than company news; its Q2 earnings call is upcoming. Dave & Buster’s shares fell 4.72% after earnings missed on revenue, profit, and comps, raising questions about future sales and free-cash-flow targets. Nokia shares dropped 3.32% in Helsinki after a recent surge, with its ADR slightly up in New York; the company is set to report soon. Ford shares lagged the S&P 500, with the company seeking to continue importing China-built Lincoln Nautilus as new U.S. rules for connected-car software approach.
Merck stock rises as $70 billion growth target sharpens focus ahead of Feb. 3 earnings

Merck stock rises as $70 billion growth target sharpens focus ahead of Feb. 3 earnings

Merck shares closed up 2.54% at $111.01 Wednesday, outperforming a falling U.S. market. Management raised forecasts for new drugs, projecting $70 billion in revenue from growth drivers by the mid-2030s. CEO Rob Davis said Merck has capacity for major deals and is running 80 phase three trials. Investors are watching for Feb. 3 earnings to assess the 2026 outlook.
15 January 2026
···
Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom

Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom

Thermo Fisher shares closed up 2.4% at $621.83 Wednesday and held steady after hours, following news of new U.S. drug manufacturing contracts. CEO Marc Casper cited a focus on reshoring production from Europe and Asia. A recent SEC filing detailed leadership changes effective in March, including COO Michel Lagarde’s exit. The company also announced a partnership with Nvidia to expand AI in lab automation.
15 January 2026
····
Morgan Stanley stock slips before earnings as Wall Street digests big-bank signals

Morgan Stanley stock slips before earnings as Wall Street digests big-bank signals

Morgan Stanley shares fell 1.1% to $180.78 Wednesday, lagging peers ahead of its quarterly earnings due before Thursday’s open. Investors are focused on trading and wealth management results after a sector rally and mixed bank earnings. After-hours trading showed little movement. U.S. bank stocks slipped as policy uncertainty and uneven results weighed on sentiment.
15 January 2026
··
NASA rushes SpaceX Crew-11 home after astronaut falls ill in orbit

NASA rushes SpaceX Crew-11 home after astronaut falls ill in orbit

SpaceX’s Crew Dragon undocked from the International Space Station Wednesday after a crew member developed a serious medical condition, NASA said. The capsule, carrying four astronauts, is targeting splashdown off California early Thursday. NASA reported the affected astronaut is stable but gave no details. This marks the first time a medical issue has forced an early return from the station.
15 January 2026
··
Accenture stock jumps after hours as Infosys outlook lifts IT services mood

Accenture stock jumps after hours as Infosys outlook lifts IT services mood

Accenture shares rose 4.3% to $288.54 in after-hours trading Wednesday, outpacing a broader market decline. Infosys raised its full-year revenue growth forecast to 3–3.5%, citing resilient tech spending. Trading volume in Accenture topped 6 million shares. Investors are watching Accenture’s Jan. 28 shareholder meeting and March earnings update.
15 January 2026
·····
Mastercard stock steadies after Washington jolt as Jan. 29 earnings loom

Mastercard stock steadies after Washington jolt as Jan. 29 earnings loom

Mastercard shares closed at $547.99 on Wednesday, up 0.6%, then slipped to $546.82 in after-hours trading amid renewed U.S. political pressure on credit-card fees. Senators reintroduced the Credit Card Competition Act, targeting Visa and Mastercard’s control over transaction routing. Analysts warn valuations could drop 10%–20%. Mastercard reports fourth-quarter earnings Jan. 29.
15 January 2026
··
Johnson & Johnson stock rises after Tecvayli trial win as JNJ eyes earnings

Johnson & Johnson stock rises after Tecvayli trial win as JNJ eyes earnings

Johnson & Johnson shares rose 2.3% to $218.55 in after-hours trading Wednesday after reporting its Tecvayli drug cut the risk of disease progression or death by 71% in a late-stage multiple myeloma trial. An independent committee recommended unblinding the study. Full results will be presented at an upcoming medical meeting. Investors await the company’s quarterly results next week.
15 January 2026
···
Chevron stock rises on report U.S. may widen Venezuela license as earnings near

Chevron stock rises on report U.S. may widen Venezuela license as earnings near

Chevron shares rose 2.1% to $167.24 in after-hours trading after reports the U.S. will broaden its Venezuela license, possibly boosting production and exports. Drones struck two oil tankers in the Black Sea Tuesday, including one chartered by Chevron; all crew are safe. The S&P 500 fell 0.53%, while energy stocks outperformed. Chevron’s Q4 earnings call is scheduled for Jan. 30.
15 January 2026
···
Wells Fargo stock drops after earnings miss as rate-cap fears linger — what to watch next

Wells Fargo stock drops after earnings miss as rate-cap fears linger — what to watch next

Wells Fargo shares fell 4.6% to $89.25 in after-hours trading after quarterly earnings and a 2026 net interest income forecast missed expectations. Executives cited uncertainty over a proposed federal cap on credit card rates. The bank posted $21.29 billion in revenue and $5.36 billion in net income for the quarter. Wells Fargo set aside $612 million for severance, signaling more layoffs ahead.
14 January 2026
··
Citigroup stock drops after earnings: Russia exit hit, costs rise and 2026 targets take center stage

Citigroup stock drops after earnings: Russia exit hit, costs rise and 2026 targets take center stage

Citigroup shares dropped 3.3% after hours Wednesday to $112.41 following fourth-quarter net income of $2.5 billion and a $1.2 billion loss tied to its Russia exit. Operating expenses rose 6% to $13.84 billion. CEO Jane Fraser told staff job cuts will continue as automation expands. Citi’s 2026 targets depend on cost reductions and steady revenue growth.
14 January 2026
··
Lam Research stock falls despite fresh target hikes; earnings and new chip tariffs loom

Lam Research stock falls despite fresh target hikes; earnings and new chip tariffs loom

Lam Research fell 2.6% to $208.79 in after-hours trading Wednesday, extending a two-day slide from Monday’s $222.58 peak. The Nasdaq dropped 1% as tech stocks retreated, despite new price-target upgrades for Lam from Stifel, RBC, and Bank of America. Investors are awaiting TSMC’s guidance Thursday and Lam’s Jan. 28 earnings. Trading volume for Lam reached about 18.2 million shares.
14 January 2026
···
Dow Jones Industrial Average slips after bank earnings, tech slide; Goldman and inflation data next

Dow Jones Industrial Average slips after bank earnings, tech slide; Goldman and inflation data next

The Dow closed down 42.36 points, or 0.09%, at 49,149.63, as tech and financial shares fell. Bank stocks slid after Wells Fargo missed profit targets and Citigroup signaled more layoffs. Visa dropped 4.5% following President Trump’s proposal to cap credit-card interest rates. Investors await Goldman Sachs earnings and a delayed inflation report.
14 January 2026
········
Palantir stock (PLTR) dips after hours as Citi upgrade meets Feb. 2 earnings countdown

Palantir stock (PLTR) dips after hours as Citi upgrade meets Feb. 2 earnings countdown

Palantir shares fell 0.3% to $178.40 in after-hours trading Wednesday, despite Citi upgrading the stock to Buy and raising its price target to $235. The stock moved between $174 and $181.33 during the session, with about 33 million shares traded. Palantir will report fourth-quarter and full-year 2025 results on Feb. 2. Broader tech stocks also declined, with the Nasdaq-focused QQQ ETF down 1.1%.
14 January 2026
···
Unity Software stock sinks nearly 8% as Wall Street eyes Feb. 11 earnings

Unity Software stock sinks nearly 8% as Wall Street eyes Feb. 11 earnings

Unity Software shares fell 7.8% to $42.12 Wednesday, extending losses in software stocks as the iShares Tech-Software ETF dropped 2.3%. The company set its Q4 and full-year 2025 earnings release for Feb. 11 and implemented a 5% price hike on Pro and Enterprise plans this week. Morgan Stanley raised its target to $52 Tuesday. Unity touched a session low of $40.76.
14 January 2026
···
1 … 141 142 143 144 145 … 257

Stock Market Today

  • NSD Shares Trade 45.2% Below Fair Value Despite May Sales Growth
    June 19, 2026, 5:58 AM EDT. NSD (TSE:9759) reported higher preliminary net sales for May 2026, yet its stock price has dropped 7.0% in one month and nearly 28% year-to-date, indicating short-term pressure despite a 51.36% gain over five years. Trading at a price-to-earnings (P/E) ratio of 14.3x, NSD is undervalued compared with the industry average of 14.5x and peer average of 15.8x, and well below its estimated fair P/E of 17.6x. The company's earnings have grown 12.7% annually over five years with a net profit margin of 11%, but a Return on Equity of 17.6% is considered low, keeping investor caution high. Market sentiment appears to price in risks including potential IT budget cuts, suggesting room for stock rerating if confidence improves.

Latest articles

Novo Nordisk Shares Rise As Ozempic Study Shows 15% Weight Loss In Older Adults

Novo Nordisk Shares Climb with OMXC25 as Healthcare Stocks Pull Higher

19 June 2026
Novo Nordisk B shares surged 5% to 294.4 Danish crowns in Copenhagen trading after the company reported limited business impact from an IT security incident, while investors focused on progress in the oral weight-loss drug race with Eli Lilly and awaited regulatory moves in China.
Intel Shares Drop Even as Tech Climbs—AI Trade Not Enough

Intel hits record close as foundry focus sharpens before week ahead

19 June 2026
Intel surged 10.64% to a record $133.99 after President Trump said Apple agreed to work with Intel on U.S. chip design and production, signaling possible steady demand and helping close the gap with TSMC; Apple and Intel did not comment, and details on chip types and deal size remain unknown.
Nvidia Stock Holds Near $5 Trillion as China Vera Chip Push and AI Benchmark Put NVDA in Focus

Nvidia ends up ahead of Juneteenth, chip names eye AI moves next week

19 June 2026
Nvidia surged 2.95% to $210.69 before the Juneteenth break as investors piled back into chip stocks, with 241 million shares traded Thursday; the move highlights Nvidia’s outsized influence on the Nasdaq and S&P 500, and sets the stage for Monday’s open and Micron’s June 24 earnings to test whether AI chip momentum holds.
Go toTop